Last reviewed · How we verify
Dextrose prolotherapy injection
At a glance
| Generic name | Dextrose prolotherapy injection |
|---|---|
| Also known as | Regenerative injection therapy |
| Sponsor | Mustafa Kemal University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Dextrose Hydrodissection for Post-Breast Cancer Chest Wall and Axillary Tightness. (NA)
- Comparison of Platelet-Rich Plasma and Prolotherapy for Plantar Fasciitis (NA)
- Comparison of Hyaluronic Acid, Injectable Platelet-Rich Fibrin, and Prolotherapy in TMJ Arthrocentesis (NA)
- Effects of Dextrose Prolotherapy in Rotator Cuff Disease (NA)
- The Ultrasound-Guided Dextrose Prolotherapy in Ehlers-Danlos Syndrome Patients (PHASE3)
- Comparison of Prolotherapy and Rehabilitation Treatments in Low Back Pain (CPRTLBP) (NA)
- Combined Effect of Prolotherapy and Personalized Physical Activity on Knee Osteoarthritis Progression (NA)
- The Effects of 15% Dextrose Solution on Pain and Range of Motion in the Hemiplegic Shoulder (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |